New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab
Özgür Akgül(Erciyes University), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Mustafa Çalış(Erciyes University)
Cited by 3
Related Papers
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
|Annals of the Rheumatic Diseases|2015|268
Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
|Molecular and Cellular Biochemistry|2006|204
Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis
|Rheumatology International|2010|140